HIROTSU Bioscience Inc.

address

Takaaki Hirotsu, President and CEO of HIROTSU Bio Science Inc.

genre

facility details: Manage risk with a simple primary screening test, leading to "early detection."
HIROTSU Bioscience's nematode cancer test, 'N-NOSE,' is a simple, affordable, painless, and highly accurate primary screening test that can help with early detection. It comprehensively checks for cancer risk throughout the entire body.

By lowering the psychological and financial barriers to cancer testing, we aim to alleviate concerns such as, "I'm worried about cancer, but undergoing various tests seems overwhelming." Our goal is to increase awareness of cancer risk management among as many people as possible and provide a starting point for a series of cancer screenings.

(This program is designed for those living overseas.)

for more details information about this program,
kindly inquire from here

the program able to have in this facility

The primary cancer screening test "N-NOSE"

implementation facility

implementation facility